NVS: Novartis AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 193,179.55
Enterprise Value ($M) 211,318.55
Book Value ($M) 60,898.00
Book Value / Share 28.31
Price / Book 3.17
NCAV ($M) -20,612.00
NCAV / Share -9.58
Price / NCAV -9.37

Profitability (mra)
Return on Invested Capital (ROIC) 0.24
Return on Assets (ROA) 0.18
Return on Equity (ROE) 0.38

Liquidity (mrq)
Quick Ratio 1.07
Current Ratio 1.31

Balance Sheet (mrq) ($M)
Current Assets 36,954.00
Assets 118,464.00
Liabilities 57,566.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-04 13G BlackRock Inc. 5.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-12-01 146,503 1,440,473 10.17
2022-11-30 381,222 2,774,979 13.74
2022-11-29 152,710 1,368,181 11.16
2022-11-28 146,846 990,087 14.83

(click for more detail)

Similar Companies
MYOV – Myovant Sciences Ltd. NUVB – Nuvation Bio Inc
NVO – Novo-Nordisk A/S OGN – Organon & Co.
PBH – Prestige Brands Holdings, Inc.


Financial data and stock pages provided by
Fintel.io